Search All News
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
A new study in women found that shortening sleep by just 90 minutes for a few weeks increased insulin resistance, a risk factor for type 2 diabetes.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
- September 8, 2015
A study by Mailman School of Public Health researchers links exposure to famine in the first trimester of pregnancy with the risk of developing diabetes in later life.
- September 2, 2015
A neuroscientist and obesity researcher at the Naomi Berrie Diabetes Center is mapping the regions of the brain that either respond or fail to respond to weight loss.
- August 31, 2015
An analysis documents worse outcomes and burgeoning costs for patients with diabetes who have coronary artery disease that requires surgery.
- April 7, 2015
Researchers have found a cellular defect that can impair the body’s ability to handle high glucose levels, pointing the way to new treatments for diabetes.
- January 22, 2015
A round-up of the Mailman School's recent research and upcoming events on obesity prevention.